FDA Inspection 1064352 — Catalent Ontario Limited
The FDA completed an inspection of Catalent Ontario Limited on June 29, 2018 in Windsor. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- June 29, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Windsor (Canada)
Additional Details
Bioanalytical BA/BE